4SC AG Aktien im Umlauf
Was ist das Aktien im Umlauf von 4SC AG?
Aktien im Umlauf von 4SC AG ist 50.570M
Was ist die Definition von Aktien im Umlauf?
Im Umlauf befindliche Aktien sind alle Aktien einer Gesellschaft oder eines finanziellen Vermögenswertes, die von Anlegern genehmigt, ausgegeben und gekauft wurden und von diesen gehalten werden.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Aktien im Umlauf von Unternehmen in Health Care Sektor auf XETRA im Vergleich zu 4SC AG
Was macht 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Unternehmen mit aktien im umlauf ähnlich 4SC AG
- Renewable Inc hat Aktien im Umlauf von 50.507M
- Gespeg Resources hat Aktien im Umlauf von 50.509M
- Cosmo Metals hat Aktien im Umlauf von 50.510M
- Cooper Tire & Rubber Co hat Aktien im Umlauf von 50.524M
- KFG Resources hat Aktien im Umlauf von 50.540M
- Cohen & Steers hat Aktien im Umlauf von 50.551M
- 4SC AG hat Aktien im Umlauf von 50.570M
- Tata Investment hat Aktien im Umlauf von 50.595M
- Tata Investment hat Aktien im Umlauf von 50.595M
- abrdn Healthcare Investors hat Aktien im Umlauf von 50.625M
- HeadHunter PLC hat Aktien im Umlauf von 50.636M
- Onxeo SA hat Aktien im Umlauf von 50.647M
- Forestar Inc hat Aktien im Umlauf von 50.654M